Here's how ASX cannabis shares are being impacted by COVID-19

Althea Group Holdings Ltd (ASX:AGH) and other ASX cannabis shares have fallen heavily this month because of the coronavirus. Will it continue?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price has fallen materially over the last few weeks following the coronavirus-induced market volatility.

In fact, it isn't just Althea which has been impacted. The likes of Auscann Group Holdings Ltd (ASX: AC8) and Cann Group Ltd (ASX: CAN) have also fallen heavily during this time.

All three are down almost 50% from recent highs, which is significantly more than the S&P/ASX 200 Index (ASX: XJO).

Why have they crashed lower?

The first reason for the sharp decline is of course the high risk nature of their shares. Given their limited revenues in a market which is largely in its infancy, investors were quick to sell them off and switch to safer options.

In addition to this, there are concerns about the impact the coronavirus is having on visits to the doctors. If potential patients are staying away from medical centres because of the outbreak, then prescription growth could be impacted greatly.

This could put pressure on their balance sheets and require further funding in the short to medium term.

How are they adapting?

This morning Althea released an update and advised how it is aiming to combat this potential headwind.

According to the release, the company is working closely with Healthcare Professionals (HCPs) and pharmacies to minimise any disruption to its patients.

This includes promoting telehealth services, fast tracking use of electronic prescriptions, and launching an e-commerce sales option via Althea Concierge platform.

How has it performed in March?

Positively, Althea has yet to be impacted materially and has continued its positive form in March.

According to the release, the month of March is on track to be the highest revenue month in Althea's history. This has been driven by strong uptake from new patients and the "recurring revenue" it is generating from repeat patients.

This news has certainly gone down well with its shareholders. In morning trade the Althea share price has rocketed almost 17% higher to 24.5 cents.

However, time will tell if these initiatives are enough to maintain its growth in April and beyond.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Coronavirus News

Man with his hand on his face looking at a falling share price chart on a tablet.
Share Market News

ASX 200 stocks dive 2.4% in worst trading day since Ukraine crisis hit

It's not a good start to the week for the market.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand. representing the falling Air New Zealand share price today
Travel Shares

Borders just reopened so why is the Flight Centre (ASX:FLT) share price falling today?

Experts believe it may take several years for tourism levels to rebound to pre-pandemic numbers.

Read more »

A worker in hi vis gear holds his hand up saying no.
Coronavirus News

Own BHP (ASX:BHP) shares? Here's how the ASX 200 miner is battling COVID

Mining unions have not generally supported mandatory vaccinations.

Read more »

Female worker sitting desk with head in hand and looking fed up
Coronavirus News

Here's what Rio Tinto (ASX:RIO) boss says is 'causing some challenges' right now

The Omicron variant is spreading in Western Australia.

Read more »

A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
Coronavirus News

Why are ASX COVID test shares climbing today?

COVID-19 tests are in focus again today.

Read more »

a girl stands in an apple orchard holding two red apples in raised arms with a happy, celebratory look on her face with a large smile and a pretty country background to the picture.
Economy

CBA reveals the Australian economy's leading state amid COVID surge

The states and territories have all been impacted by the pandemic.

Read more »

Rapid Antigen Test taking place.
Share Market News

Why is Ellume hitting headlines today?

Brisbane-based diagnostics developer Ellume is back in the headlines.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Share Market News

Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

Read more »